Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Chief Sales Officer | May 25, 2017 | May 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date May 25, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,710 |
Reported balance
After 2017-05-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-25 · Grant · Acquired 10,710 · Balance 10,710 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: The restricted stock unit vests in four equal annual installments beginning March 3, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 10,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008195 · edgar.xml · derivative · entry 1 King Michael H. · CIK 0001646487 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,710 Underlying: Common Stock · 10,710 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. F2 · derivative.expiration_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 23:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $25.75 | $128,750.00 |
DisclosureSEC source: 0001179110-17-006158 · edgar.xml · nonDerivative · entry 1 King Michael H. · CIK 0001646487 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,459 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2016. F1 · price: Represents the weighted average price of transactions ranging from $25.15 to $26.15. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 23:46 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 95,115 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-17-004169 · edgar.xml · derivative · entry 1 King Michael H. · CIK 0001646487 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,115 Underlying: Common Stock · 95,115 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 3, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 19, 2017 Filed Jan 23, 2017 23:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $19.00 | $95,000.00 |
DisclosureSEC source: 0001179110-17-001186 · edgar.xml · nonDerivative · entry 1 King Michael H. · CIK 0001646487 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,459 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2016. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 23:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $19.00 | $95,000.00 |
DisclosureSEC source: 0001179110-16-032641 · edgar.xml · nonDerivative · entry 1 King Michael H. · CIK 0001646487 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,459 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.